Evelo Biosciences, Inc. – NASDAQ:EVLO
Evelo Biosciences stock price today
$0.001
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 17 hours
Evelo Biosciences stock price monthly change
+900.00%
month
Evelo Biosciences stock price quarterly change
+900.00%
quarter
Evelo Biosciences stock price yearly change
-98.33%
year
Evelo Biosciences key metrics
Market Cap | 9.49K |
Enterprise value | N/A |
P/E | -0.16 |
EV/Sales | N/A |
EV/EBITDA | 0.14 |
Price/Sales | N/A |
Price/Book | -3.19 |
PEG ratio | N/A |
EPS | -13.35 |
Revenue | N/A |
EBITDA | -73.55M |
Income | -82.34M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEvelo Biosciences stock price history
Evelo Biosciences stock forecast
Evelo Biosciences financial statements
| Dec 2022 | 0 | -23.54M | |
|---|---|---|---|
| Mar 2023 | 0 | -25.34M | |
| Jun 2023 | 0 | -21.10M | |
| Sep 2023 | 0 | -12.36M |
| 2025 | 0 | -5.38M |
|---|
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 64441000 | 69.43M | 107.75% |
|---|---|---|---|
| Mar 2023 | 41970000 | 69.35M | 165.26% |
| Jun 2023 | 20819000 | 66.94M | 321.56% |
| Sep 2023 | 20627000 | 47.33M | 229.48% |
| Dec 2022 | -23.19M | -228K | 1.73M |
|---|---|---|---|
| Mar 2023 | -20.27M | -12K | -199K |
| Jun 2023 | -19.82M | -12K | -199K |
| Sep 2023 | -10.40M | 513K | 19.22M |
Evelo Biosciences alternative data
| Aug 2023 | 66 |
|---|---|
| Sep 2023 | 66 |
| Oct 2023 | 66 |
| Nov 2023 | 66 |
| Dec 2023 | 66 |
| Jan 2024 | 66 |
| Feb 2024 | 66 |
| Mar 2024 | 66 |
| Apr 2024 | 66 |
| May 2024 | 66 |
| Jun 2024 | 66 |
| Jul 2024 | 66 |
Evelo Biosciences other data
34.25%
-46.30%
of EVLO is owned by hedge funds
23
-18
29.85M
-57.18M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2023 | 0 | 151 |
| May 2023 | 0 | 199383 |
| Jul 2023 | 5411255 | 0 |
| Aug 2023 | 0 | 8908 |
| Sep 2023 | 0 | 1996 |
| Nov 2023 | 0 | 17707 |
| Patent |
|---|
Application Filling date: 31 Jul 2020 Issue date: 25 Aug 2022 |
Application Filling date: 11 Jun 2020 Issue date: 11 Aug 2022 |
Application COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISORDERS USING IMMUNE MODULATING LACTOCOCCUS BACTERIA STRAINS Filling date: 25 Jan 2022 Issue date: 7 Jul 2022 |
Application Filling date: 21 Feb 2020 Issue date: 21 Apr 2022 |
Grant Filling date: 29 Aug 2018 Issue date: 8 Feb 2022 |
Application Filling date: 6 Jul 2021 Issue date: 28 Oct 2021 |
Grant Utility: Compositions and methods for treating cancer and immune disorders using Veillonella bacteria Filling date: 6 Feb 2019 Issue date: 17 Aug 2021 |
Grant Utility: Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome Filling date: 25 Nov 2015 Issue date: 20 Apr 2021 |
Application Filling date: 26 Aug 2020 Issue date: 1 Apr 2021 |
Application Filling date: 31 Jan 2019 Issue date: 25 Feb 2021 |
| Quarter | Transcript |
|---|---|
| Q4 2022 16 Mar 2023 | Q4 2022 Earnings Call Transcript |
| Q2 2022 11 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q4 2021 24 Mar 2022 | Q4 2021 Earnings Call Transcript |
| Q3 2021 28 Oct 2021 | Q3 2021 Earnings Call Transcript |
-
What's the price of Evelo Biosciences stock today?
One share of Evelo Biosciences stock can currently be purchased for approximately $0.
-
When is Evelo Biosciences's next earnings date?
Unfortunately, Evelo Biosciences's (EVLO) next earnings date is currently unknown.
-
Does Evelo Biosciences pay dividends?
No, Evelo Biosciences does not pay dividends.
-
How much money does Evelo Biosciences make?
Evelo Biosciences has a market capitalization of 9.49K.
-
What is Evelo Biosciences's stock symbol?
Evelo Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "EVLO".
-
What is Evelo Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Evelo Biosciences?
Shares of Evelo Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Evelo Biosciences have?
As Jul 2024, Evelo Biosciences employs 66 workers.
-
When Evelo Biosciences went public?
Evelo Biosciences, Inc. is publicly traded company for more then 7 years since IPO on 8 May 2018.
-
What is Evelo Biosciences's official website?
The official website for Evelo Biosciences is evelobio.com.
-
Where are Evelo Biosciences's headquarters?
Evelo Biosciences is headquartered at 620 Memorial Drive, Cambridge, MA.
-
How can i contact Evelo Biosciences?
Evelo Biosciences's mailing address is 620 Memorial Drive, Cambridge, MA and company can be reached via phone at +61 75770300.
Evelo Biosciences company profile:
Evelo Biosciences, Inc.
evelobio.comExchange:
NASDAQ
Full time employees:
66
Industry:
Biotechnology
Sector:
Healthcare
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
620 Memorial Drive
Cambridge, MA 02139
Cambridge, MA 02139
CIK: 0001694665
ISIN: US2997342025
CUSIP: 299734103
